Maccura Biotechnology Valuation
| 300463 Stock | 13.49 0.05 0.37% |
At this time, the firm appears to be fairly valued. Maccura Biotechnology secures a last-minute Real Value of USD13.53 per share. The latest price of the firm is USD13.49. Our model forecasts the value of Maccura Biotechnology from analyzing the firm fundamentals such as Profit Margin of 0.12 %, current valuation of 8.03 B, and Return On Equity of 0.0485 as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.2596 | Enterprise Value 8 B | Enterprise Value Ebitda 23.2829 | Price Sales 3.0373 | Trailing PE 25.3396 |
Fairly Valued
Today
Please note that Maccura Biotechnology's price fluctuation is not too volatile at this time. Calculation of the real value of Maccura Biotechnology is based on 3 months time horizon. Increasing Maccura Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Maccura Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Maccura Stock. However, Maccura Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.49 | Real 13.53 | Hype 13.45 | Naive 13.43 |
The real value of Maccura Stock, also known as its intrinsic value, is the underlying worth of Maccura Biotechnology Company, which is reflected in its stock price. It is based on Maccura Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Maccura Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Maccura Biotechnology Co helps investors to forecast how Maccura stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Maccura Biotechnology more accurately as focusing exclusively on Maccura Biotechnology's fundamentals will not take into account other important factors: Maccura Biotechnology Cash |
|
Maccura Biotechnology Total Value Analysis
Maccura Biotechnology Co is presently forecasted to have takeover price of 8.03 B with market capitalization of 8.29 B, debt of 144.65 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Maccura Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.03 B | 8.29 B | 144.65 M |
Maccura Biotechnology Investor Information
About 40.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.26. In the past many companies with similar price-to-book ratios have beat the market. Maccura Biotechnology last dividend was issued on the 3rd of July 2024. The entity had 30:10 split on the 8th of June 2016. Based on the key measurements obtained from Maccura Biotechnology's financial statements, Maccura Biotechnology Co is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 592.4 M | 1 B |
|
| |||||
| Operating Income | 651 M | 519.2 M |
|
|
Maccura Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Maccura Biotechnology has an asset utilization ratio of 35.67 percent. This suggests that the Company is making USD0.36 for each dollar of assets. An increasing asset utilization means that Maccura Biotechnology Co is more efficient with each dollar of assets it utilizes for everyday operations.Maccura Biotechnology Ownership Allocation
Maccura Biotechnology maintains a total of 612.47 Million outstanding shares. Maccura Biotechnology Co holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Maccura Biotechnology Profitability Analysis
The company reported the revenue of 2.9 B. Net Income was 312.62 M with profit before overhead, payroll, taxes, and interest of 1.46 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Maccura Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Maccura Biotechnology and how it compares across the competition.
About Maccura Biotechnology Valuation
The stock valuation mechanism determines Maccura Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of Maccura Biotechnology. We calculate exposure to Maccura Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Maccura Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.8 B | 1.6 B |
Maccura Biotechnology Quarterly Retained Earnings |
|
Complementary Tools for Maccura Stock analysis
When running Maccura Biotechnology's price analysis, check to measure Maccura Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maccura Biotechnology is operating at the current time. Most of Maccura Biotechnology's value examination focuses on studying past and present price action to predict the probability of Maccura Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maccura Biotechnology's price. Additionally, you may evaluate how the addition of Maccura Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |